Literature DB >> 12522838

Attentional functioning in fibromyalgia, rheumatoid arthritis, and musculoskeletal pain patients.

Bruce Dick1, Chris Eccleston, Geert Crombez.   

Abstract

OBJECTIVES: To investigate whether chronic pain patients have deficits in attentional functioning compared with pain-free controls, and whether fibromyalgia patients have larger deficits in attentional functioning compared with rheumatoid arthritis and musculoskeletal pain patients.
METHODS: Sixty patients (20 in each of 3 patient groups) and 20 pain-free controls completed measures assessing pain intensity, mood, pain-related disability, somatic awareness, and catastrophic thinking about pain. Attentional functioning was assessed using an age-standardized, ecologically valid test battery. Analyses were made of between-group differences.
RESULTS: Sixty percent of patients had at least one score in the clinical range of neuropsychological impairment, independent of demography and mood. Fibromyalgia patients were more anxious and somatically aware than rheumatoid arthritis or musculoskeletal pain patients, but did not show larger attentional deficits than other patient groups.
CONCLUSION: All 3 groups of chronic pain patients, regardless of diagnosis, had impaired cognitive functioning on an ecologically sensitive neuropsychological test of everyday attention.

Entities:  

Mesh:

Year:  2002        PMID: 12522838     DOI: 10.1002/art.10800

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  62 in total

1.  Executive function in chronic pain patients and healthy controls: different cortical activation during response inhibition in fibromyalgia.

Authors:  Jennifer M Glass; David A Williams; Maria-Luisa Fernandez-Sanchez; Anson Kairys; Paloma Barjola; Mary M Heitzeg; Daniel J Clauw; Tobias Schmidt-Wilcke
Journal:  J Pain       Date:  2011-09-25       Impact factor: 5.820

Review 2.  The effects of meditation-based interventions on the treatment of fibromyalgia.

Authors:  Elisa H Kozasa; Luiza H Tanaka; Carlos Monson; Stephen Little; Frederico Camelo Leao; Mario P Peres
Journal:  Curr Pain Headache Rep       Date:  2012-10

3.  The Relationship Between Chronic Pain and Neurocognitive Function: A Systematic Review.

Authors:  Diana M Higgins; Aaron M Martin; Dewleen G Baker; Jennifer J Vasterling; Victoria Risbrough
Journal:  Clin J Pain       Date:  2018-03       Impact factor: 3.442

Review 4.  Transcranial Direct Current Stimulation as a Therapeutic Tool for Chronic Pain.

Authors:  Camila Bonin Pinto; Beatriz Teixeira Costa; Dante Duarte; Felipe Fregni
Journal:  J ECT       Date:  2018-09       Impact factor: 3.635

Review 5.  [Cognitive impairment in patients suffering from fibromyalgia. An underestimated problem].

Authors:  T Schmidt-Wilcke; P Wood; R Lürding
Journal:  Schmerz       Date:  2010-02       Impact factor: 1.107

6.  Understanding fibromyalgia and its related disorders.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2008

7.  Academic aptitude as a predictor of headache proneness during college: could headache be an outcome of low test scores?

Authors:  Christine A Hovanitz; Dawn Lindsay Thatcher
Journal:  Int J Behav Med       Date:  2012-03

8.  Neuropathic Pain Creates an Enduring Prefrontal Cortex Dysfunction Corrected by the Type II Diabetic Drug Metformin But Not by Gabapentin.

Authors:  Stephanie Shiers; Grishma Pradhan; Juliet Mwirigi; Galo Mejia; Ayesha Ahmad; Sven Kroener; Theodore Price
Journal:  J Neurosci       Date:  2018-07-20       Impact factor: 6.167

9.  Pain moderates changes in psychological flexibility but not substance use symptoms during substance use disorder treatment.

Authors:  Katherine T Foster; Colleen Ehrnstrom; Stephen Chermack; Avinash Hosanagar
Journal:  Psychiatry Res       Date:  2016-08-05       Impact factor: 3.222

10.  Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in diabetic neuropathic pain.

Authors:  Franco Cauda; Katiuscia Sacco; Federico D'Agata; Sergio Duca; Dario Cocito; Giuliano Geminiani; Filippo Migliorati; Gianluca Isoardo
Journal:  BMC Neurosci       Date:  2009-11-26       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.